Insights on Melanoma
Teresa Amaral, MD, PhD, is the Head of the Skin Cancer Clinical Trials Center at the University of Tübingen, Germany. Her research focuses on predictive biomarkers for systemic therapy in advanced melanoma and prognostic biomarkers in early-stage melanoma. She serves as Chair of the ESMO Leadership Development Committee and is a member of the ESMO Melanoma and Other Skin Tumours Faculty.- Who Really Needs Treatment? The Biomarker Challenge
- Refining Melanoma Treatment With Biomarker-Driven Insights
- Reducing Administrative Burden in Clinical Trials
- Redesigning Clinical Trials for Real-World Impact
- Considerations for Simpler and More Relevant Clinical Trials
- Continuing Melanoma Research: Why, How, What?